The SASP and/or MTX treatments altered the protein profiles of exosomes and suppressed the effects of IL-1β on the exosomal proteome. Exosomes may play roles in the actions of these anti-rheumatic drugs.
No takes yet. Share an insight, caveat, or question.
Tsuno et al. (2015) studied this question.